A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the efficacy and safety of TQB2450 injection or combined with
anlotinib hydrochloride capsule in the treatment of recurrent or metastatic advanced
endometrial cancer.